ClinicalTrials.gov
public full text
Public Domain
A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS
This is a PAC study after PCV13 launch in China. Based on recommendation from China Agency, Pfizer was required to conduct a descriptive immunogenicity study to measure the antibody levels at the time of disease onset.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Construction of Special Disease Cohort Database and Biological Sample Holographic Database of Severe Pneumonia#1195807
- Estimating clinical and economic impacts and cost-effectiveness of introducing 20-valent pneumococcal conjugate vaccine in Taiwan's pediatric National Immunization Program and impacts of a delayed implementation#642294
- Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires#1161344
- COVID-19 Child Health Investigation of Latent Disease in Hamburg#1260736
- Evaluation of early diagnostic approaches for malaria and pneumonia in children under-five presenting at the primary healthcare level in Benin City, Nigeria: a mixed methods study#649243
Record · ID 1484108
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive